MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare – how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health.

The Company is backed by Bain Capital Ventures  and Emergence Capital Partners. Thoma Bravo made a majority investment in the Company in September 2015.